| P2093 | author name string | G Tiegs | |
| | M C Meyer | |
| | R A K Stahl | |
| | M A Kluger | |
| | A Nosko | |
| | B Goerke | |
| | C Wegscheid | |
| | M Luig | |
| | O M Steinmetz | |
| | T Ramcke | |
| P2860 | cites work | Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases | Q24607561 |
| | The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity | Q24805385 |
| | TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy | Q84973156 |
| | Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane | Q87292752 |
| | Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients | Q89361803 |
| | Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus | Q28088753 |
| | Pathogenesis of kidney disease in systemic lupus erythematosus | Q30434907 |
| | Stat3 programs Th17-specific regulatory T cells to control GN. | Q33660684 |
| | Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus | Q33923351 |
| | CCR6 recruits regulatory T cells and Th17 cells to the kidney in glomerulonephritis | Q33979326 |
| | REV-ERB and ROR nuclear receptors as drug targets. | Q34407313 |
| | Runx1 and Runx3 are involved in the generation and function of highly suppressive IL-17-producing T regulatory cells | Q34416390 |
| | The Th17-defining transcription factor RORγt promotes glomerulonephritis | Q34695374 |
| | CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. | Q35006074 |
| | Oral interleukin-10 alleviates polyposis via neutralization of pathogenic T-regulatory cells | Q35067193 |
| | Animal Models of Interferon Signature Positive Lupus | Q35686914 |
| | MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORγt⁺ T cells | Q35687488 |
| | Inflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN. | Q35790589 |
| | Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells | Q36373858 |
| | RORγt(+)Foxp3(+) Cells are an Independent Bifunctional Regulatory T Cell Lineage and Mediate Crescentic GN | Q36514880 |
| | Interleukin-17 cytokines are critical in development of fatal lupus glomerulonephritis | Q36676453 |
| | In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells | Q36699777 |
| | Taming lupus-a new understanding of pathogenesis is leading to clinical advances | Q36712941 |
| | Identification of Potent and Selective Diphenylpropanamide RORγ Inhibitors | Q37163665 |
| | Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. | Q37208910 |
| | Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. | Q37351980 |
| | The role of IL-23/IL-17 axis in lupus nephritis | Q37397437 |
| | IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation | Q37397810 |
| | Updates on the treatment of lupus nephritis | Q37807212 |
| | The immune system and kidney disease: basic concepts and clinical implications. | Q38137749 |
| | Alveolar hemorrhage in systemic lupus erythematosus: a cohort review | Q38589244 |
| | T-Bet Enhances Regulatory T Cell Fitness and Directs Control of Th1 Responses in Crescentic GN. | Q39685878 |
| | Foxp3(+) T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation | Q40606910 |
| | Treg17 cells are programmed by Stat3 to suppress Th17 responses in systemic lupus | Q40953299 |
| | RORc Modulators for the Treatment of Autoimmune Diseases | Q42133394 |
| | Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells. | Q42667819 |
| | IL-17 promotes murine lupus. | Q45942916 |
| | IL-17F Promotes Tissue Injury in Autoimmune Kidney Diseases | Q49165257 |
| | Systemic lupus erythematosus. | Q53202066 |
| | Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus. | Q53545750 |
| | Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane | Q74129640 |
| | Disparate T cell requirements of two subsets of lupus-specific autoantibodies in pristane-treated mice | Q77291184 |
| | CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis | Q84521092 |
| | Lupus nephritis: Implications of the new ACR lupus nephritis guidelines | Q84605728 |
| P433 | issue | 1 | |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| P304 | page(s) | 63-78 | |
| P577 | publication date | 2016-11-23 | |
| P1433 | published in | Clinical and Experimental Immunology | Q15716708 |
| P1476 | title | RORγt expression in Tregs promotes systemic lupus erythematosus via IL-17 secretion, alteration of Treg phenotype and suppression of Th2 responses. | |
| P478 | volume | 188 | |